martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 3, 2025

The AI frenzy is driving a new global supply chain crisis

View original at finance.yahoo.com
The AI frenzy is driving a new global supply chain crisis By Hyunjoo Jin, Fanny Potkin, Wen-Yee Lee, Anton Bridge and Max A…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The memory price surge is significant but Nvidia has secured substantial supply

    80% confidence
  • SK Hynix is receiving requests for memory supplies from so many companies they're worried about handling all of them

    80% confidence
  • Caramon's monthly sales increased from $500,000 to $800,000-900,000 since September

    80% confidence
  • In hindsight, one could say the industry was caught off-guard

    80% confidence
  • The AI build-out is colliding with a supply chain that cannot meet its physical requirements

    80% confidence
  • Realme could be forced to lift handset prices by 20% to 30% by June 2026

    80% confidence
  • The steep increases in memory costs are unprecedented since the advent of smartphones

    80% confidence
  • The cost of storage is something all manufacturers must completely absorb with no way to transfer it

    80% confidence
  • Prices of advanced and legacy memory will rise by 30% through Q4 2025 and possibly another 20% in early 2026

    80% confidence
  • The memory shortage has now graduated from a component-level concern to a macroeconomic risk

    80% confidence
  • SK Hynix told analysts that the memory shortfall would last through late 2027

    80% confidence
  • OpenAI's Stargate project requires about double current global monthly HBM production

    80% confidence
  • Many customers have been asking Winbond for help with one requesting a six-year long-term agreement

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com